tradingkey.logo
tradingkey.logo
Pesquisar

Conmed Corp

CNMD
Adicionar à lista de desejos
33.830USD
+1.070+3.27%
Fechamento 07/02, 13:00ETCotações atrasadas em 15 min
1.02BValor de mercado
19.08P/L TTM

Mais detalhes de Conmed Corp Empresa

CONMED Corporation is a medical technology company, which provides devices and equipment for surgical procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.

Informações de Conmed Corp

Código da empresaCNMD
Nome da EmpresaConmed Corp
Data de listagemJul 23, 1987
CEOBeyer (Patrick J)
Número de funcionários3900
Tipo de títulosOrdinary Share
Fim do ano fiscalJul 23
Endereço11311 Concept Boulevard
CidadeLARGO
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal33773
Telefone17272142974
Sitehttps://www.conmed.com/
Código da empresaCNMD
Data de listagemJul 23, 1987
CEOBeyer (Patrick J)

Executivos da empresa Conmed Corp

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. David M. Bronson
Mr. David M. Bronson
Independent Director
Independent Director
17.91K
+3.73%
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
10.81K
--
Mr. Brian P. Concannon
Mr. Brian P. Concannon
Independent Director
Independent Director
10.12K
--
Ms. Barbara J. Schwarzentraub
Ms. Barbara J. Schwarzentraub
Independent Director
Independent Director
6.45K
+10.35%
Mr. Peter K Shagory
Mr. Peter K Shagory
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
3.90K
--
Ms. Hollie Foust
Ms. Hollie Foust
Executive Vice President, General Counsel and Corporate Secretary
Executive Vice President, General Counsel and Corporate Secretary
2.89K
--
Mr. Brent Lalomia
Mr. Brent Lalomia
Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations
Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations
1.04K
-8.65%
Mr. Charles (Chuck) Farkas
Mr. Charles (Chuck) Farkas
Independent Director
Independent Director
--
--
Ms. Johonna Marie Pelletier
Ms. Johonna Marie Pelletier
Treasurer and Vice President - Tax
Treasurer and Vice President - Tax
--
--
Mr. Todd W. Garner
Mr. Todd W. Garner
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. David M. Bronson
Mr. David M. Bronson
Independent Director
Independent Director
17.91K
+3.73%
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
10.81K
--
Mr. Brian P. Concannon
Mr. Brian P. Concannon
Independent Director
Independent Director
10.12K
--
Ms. Barbara J. Schwarzentraub
Ms. Barbara J. Schwarzentraub
Independent Director
Independent Director
6.45K
+10.35%
Mr. Peter K Shagory
Mr. Peter K Shagory
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
3.90K
--
Ms. Hollie Foust
Ms. Hollie Foust
Executive Vice President, General Counsel and Corporate Secretary
Executive Vice President, General Counsel and Corporate Secretary
2.89K
--

Perguntas frequentes

Quem são os cinco principais acionistas de Conmed Corp?

Os cinco principais acionistas de Conmed Corp são: Mr. David M. Bronson

Quantas instituições possuem ações da Conmed Corp (CNMD)?

Em 2026Q1, 638 instituições possuíam ações da Conmed Corp, com valor de mercado aproximado de 34.51M, representando 114.61% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -7041128.00.

Qual é a maior fonte de receita da Conmed Corp?

Em 2026Q1, o segmento de negócios General Surgery gerou a maior receita para Conmed Corp, totalizando 800.13M e representando 58.20% da receita total.